Vonoprazan Fumarate
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-15295-100 mg |
| CAS # | 881681-01-2 |
| Pricing | 100 mg, USD $50.0 |
| Synonyms | TAK-438 |
| MWt | 461.46 |
| Formula | C₂₁H₂₀FN₃O₆S |
| Biological Activity | Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease[1][2]. |
| Purity | 99.94% |